Lithium Augmentation Therapy in Tricyclic-Resistant Depression: A Controlled Trial Using Lithium in Low and Normal Doses
The DOI matches its Crossref record.
Abstract
Thirty-four patients with tricyclic-resistant depressive illness took part in a nine-week, doubleblind, placebo-controlled trial of lithium augmentation. In addition to the maximum tolerated doses of their tricyclic antidepressant, the experimental group (n= 16) received 250 mg lithium daily for three weeks, followed by 750 mg lithium daily for six weeks, while the controls (n= 18) received placebo for three weeks followed by three weeks each of 250 mg lithium daily and 750 mg lithium daily. There was no significant difference between placebo and 250 mg lithium for weeks 0-3 of the trial. However, there was a significantly greater improvement on the MADRS for weeks 3-6 for those subjects on 750 mg lithium than for those on 250 mg lithium. In addition, using a 50% fall in the HRSD as a criterion of drug responsiveness, 22% responded to placebo, 18% to 250 mg lithium, and 44% to 750mg lithium. Thus, lithium in normal, but not in low, dose has a significant antidepressant effect in TCA-resistant depression. Further controlled studies using lithium in normal dose in trials which have a greater duration of placebo exposure are required to confirm the lithium augmentation effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 39
- 10.1111/j.1476-5381.1974.tb09682.x · doi:10.1111/j.1476-5381.1974.tb09682.x
- 10.1097/00004714-198412000-00004 · doi:10.1097/00004714-198412000-00004
- 10.1111/j.1600-0447.1989.tb01306.x · DOI · Paper page
- Klein, 1980, Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children
- 10.1177/070674378603100506 · DOI
- Austin, 1990, Toxicity resulting from lithium augmentation of anti-depressant treatment in elderly patients, Journal of Clinical Psychiatry, 51, 344
- 10.1136/bmj.302.6791.1481 · DOI · Paper page
- Pai, 1986, Lithium augmentation in the treatment of delusional depression, British Journal of Psychiatry, 134, 383
- 10.1111/j.1600-0447.1974.tb08212.x · DOI
- 10.1055/s-2007-1014603 · DOI · Paper page
- 10.1192/bjp.151.2.213 · DOI
- Ghose, 1977, Lithium salts - therapeutic and unwanted effects, British Journal of Hospital Medicine, 18, 578
- Worral, 1986, Lithium augmentation of tricyclics, British Journal of Psychiatry, 149, 520, 10.1192/S0007125000139819 · doi:10.1192/s0007125000139819
- Zusky, 1986, Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo controlled study, Journal of Clinical Psychopharmacology, 8, 120
- Kushnir, 1986, Lithium antidepressant combinations in the treatment of depressed, physically ill geriatric patients, American Journal of Psychiatry, 143, 378, 10.1176/ajp.143.3.378 · DOI
- Price, 1983, Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression, American Journal of Psychiatry, 140, 318, 10.1176/ajp.140.3.318 · DOI
- 10.1016/0028-3908(82)90010-7 · DOI
- 10.1192/bjp.138.3.252 · DOI · Paper page
- 10.1001/archpsyc.1983.01790110069012 · DOI · Paper page
- Charney, 1981, Delusional and non-delusional unipolar depression: further evidence for distinct subtypes, American Journal of Psychiatry, 138, 328, 10.1176/ajp.138.3.328 · DOI · Paper page
- De Montigny, 1985, Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study, American Journal of Psychiatry, 142, 220, 10.1176/ajp.142.2.220 · doi:10.1176/ajp.142.2.220
- Goodwin, 1982, Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-responders, American Journal of Psychiatry, 139, 34, 10.1176/ajp.139.1.34 · DOI · Paper page
- Hall, 1981, Unrecognised physical illness prompting psychiatric admission: a prospective study, American Journal of Psychiatry, 138, 629, 10.1176/ajp.138.5.629 · DOI · Paper page
- 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
- 10.1001/archpsyc.1983.01790110077013 · DOI · Paper page
- 10.1192/bjp.159.4.510 · DOI · Paper page
- 10.1097/00004850-198701000-00004 · DOI
- 10.1001/archpsyc.1979.01780040056006 · DOI · Paper page
- 10.1192/bjp.153.6.741 · DOI · Paper page
- 10.1192/bjp.114.516.1365 · doi:10.1192/bjp.114.516.1365
- 10.1192/bjp.134.4.382 · DOI · Paper page
- 10.1016/S0140-6736(63)90271-X · DOI · Paper page
- Spitzer, 1975, Research Diagnostic Criteria (RDC)
- Katona, 1988, Lithium augmentation in refractory depression, Psychiatric Developments, 2, 153
- Price, 1986, Variability of response to lithium augmentation in refractory depression, American Journal of Psychiatry, 143, 1387, 10.1176/ajp.143.11.1387 · DOI
- Schou, 1990, Lithium and treatment-resistant depressions: a review, Lithium, i, 3
- 10.1192/bjp.135.3.255 · DOI · Paper page
- 10.1055/s-2007-1014602 · doi:10.1055/s-2007-1014602
- 10.1001/archpsyc.1984.01790140028003 · DOI · Paper page
Cited by
Fava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeim, H. A., Quitkin, F. M., Wisniewski, S., Lavori, P. W., Rosenbaum, J. F., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00107-7 · Cited by 519
Connolly, K. R., & Thase, M. E. (2011) · Drugs · doi:10.2165/11587620-000000000-00000 · Cited by 462
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies
Bauer, M., & Döpfmer, S. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00006 · Cited by 304
Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.134 · Cited by 215
Carvalho, A. F., Cavalcante, J. L., Castelo, M. S., & Lima, M. C. O. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00846.x · Cited by 110
Vázquez, G. H., Bahji, A., Undurraga, J., Tondo, L., & Baldessarini, R. J. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211013579 · Cited by 95
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
“They included 10 eligible RCTs, all of which were between 1 and 6 weeks in length and had been included in their previous guidelines (Zusky et al., 1988; Jensen et al., 1992; Joffe et al., 1993; Stein and Bernadt, 1993; Baumann et al., 1996; Shahal et al., 1996; Bloch et al., 1997; Cappiello et al., 1998; Januel et al…”
Background
Metadata
- Authors
- Stein, G., & Bernadt, M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1993-05
- Volume
- 162
- Issue
- 5
- Pages
- 634-640
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2143091287
- Cited by
- 118
- References
- 0
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.